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the coexistence between species that occurs in some infections remains hard to achieve in vitro 
since bacterial fitness differences eventually lead to a single organism dominating the mixed culture. 
Pseudomonas aeruginosa and Staphylococcus aureus are major pathogens found growing together in 
biofilms in disease-affected lungs or wounds. Herein, we tested and analyzed different culture media, 
additives and environmental conditions to support P. aeruginosa and S. aureus coexistence in vitro. 
We have unraveled the potential of DMEM to support the growth of these two organisms in mature 
cocultured biofilms (three days old) in an environment that dampens the pH rise. Our conditions use 
equal initial inoculation ratios of both strains and allow the stable formation of separate S. aureus 
microcolonies that grow embedded in a P. aeruginosa biofilm, as well as S. aureus biofilm overgrowth 
when bovine serum albumin is added to the system. Remarkably, we also found that S. aureus survival 
is strictly dependent on a well-characterized phenomenon of oxygen stratification present in the 
coculture biofilm. An analysis of differential tolerance to gentamicin and ciprofloxacin treatment, 
depending on whether P. aeruginosa and S. aureus were growing in mono- or coculture biofilms, was 
used to validate our in vitro coculture conditions.
Most chronic infections occur due to the inherent capacity of some bacterial pathogens to grow in biofilms1. 
Although they have been historically investigated as monoculture events, some infection-associated biofilms are 
currently recognized to be mainly polymicrobial and involve synergistic interactions that often worsen the disease 
outcome2,3.
Polymicrobial biofilms can develop greater antimicrobial resistance than single-species biofilms4. The way 
bacteria are distributed and interact with each other or with the host fluctuates depending on the environment5,6. 
For instance, Pseudomonas aeruginosa, in addition to forming large mushroom-shaped biofilm structures in vitro, 
can behave differently and form different bacterial arrangements in vivo. Clusters or aggregates perfectly arranged 
and determined by the different bacteria that are able to grow concurrently are more likely to occur during the 
establishment and persistence of the infection. Therefore, there is an intrinsic effect of the surrounding environ-
ment on the way microbes behave and establish their connections3.
Regarding human pathogenesis, cystic fibrosis (CF) is a model example of how bacterial interactions within 
biofilms can modulate the outcome of the disease, thus playing a critical role in the patient’s wellbeing7. CF 
is a lethal genetic disease characterized by the production of abnormal secretions in different organs8. Lungs 
especially are affected by CF. In the lung, a thick and dense mucus builds up over the pulmonary epithelium, 
converting it into the perfect niche for bacterial colonization and growth9,10. CF-affected lungs contain changing 
gradients of oxygen, nutrients and pH, which together provide a heterogeneous environment that favors the 
coexistence and proliferation of a wide range of microbial species and, consequently, exacerbating the progres-
sion of the disease9. P. aeruginosa and Staphylococcus aureus are two major pathogens commonly isolated from 
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CF-affected airways and sputum. Although S. aureus usually colonizes the lung epithelium during childhood and 
P. aeruginosa is more likely to be acquired in the transition to adult life, both microorganisms have been detected 
coexisting and synergistically contributing to the disease severity11,12. A similar scenario is found in infected 
wounds, where both bacterial species can often be found infecting simultaneously13. Despite the knowledge that 
both organisms can grow in unison in vivo, it remains difficult to mimic the conditions that sustain this close 
relationship in vitro.
The discovery of the culture conditions able to maintain mixed P. aeruginosa and S. aureus simultaneous 
growth in vitro has become a scientific hotspot, and several studies can be found in the bibliography addressing 
the interactions of these microorganisms. In their attempt to elucidate the principles of the coexistence of these 
species, some studies have used a higher inoculation ratio of S. aureus vs P. aeruginosa to establish the mixed 
biofilm or introduced the latter once the S. aureus biofilm has been established14. Equal inoculation ratios of both 
microorganisms have also been tested; however, coexistence under these conditions did not last longer than 24 h 
or only information related to the mixed biofilm biomass (not from each organism independently within the 
cocultured biofilm) can be found in the literature15–17. Some researchers used P. aeruginosa supernatant to evalu-
ate its impact on the coculture system18–20, while other studies were based on wound models21,22.
Our study focused on deciphering the optimal coculture conditions and environmental requisites that would 
allow the simultaneous and stable growth of P. aeruginosa and S. aureus in mixed biofilms over time. We rea-
soned that the achievement of a stable in vitro coculture biofilm, able to grow with balanced populations of both 
organisms and to remain for an extended period of time, would be useful to understand the pathophysiology 
associated with the interaction of these two-species and for generating optimized chemotherapies to treat such 
biofilm-related diseases. Therefore, we developed a combination of coculture conditions that enable the stable 
formation of P. aeruginosa and S. aureus mixed biofilms on different abiotic surfaces. The coculture biofilms 
were formed using equal initial bacterial inoculation ratios and grew stably for up to three days of testing in an 
environmental background that dampens the pH rise. Furthermore, we provide evidence that S. aureus survival 
during coculture biofilm growth with P. aeruginosa is strictly dependent on oxygen diffusion. To validate the 
combination of the coculture conditions and environmental prerequisites identified, we treated the mixed bio-
films with known antibiotics to confirm differences in antibiotic tolerance depending on whether the strains were 
growing in mono- or coculture biofilms.
Results
Testing and analyzing P. aeruginosa and S. aureus balanced population co-growth in different culture 
media. The culturing conditions able to block the antagonistic relationship between P. aeruginosa and S. aureus 
in vitro have yet to be discovered. As shown in Fig. 1a-LB, when both bacterial strains are grown together in Luria-
Bertani (LB) medium, P. aeruginosa tends to dominate the culture and compromise S. aureus survival in the system 
(at 28 h). As our goal was to achieve balanced and stable P. aeruginosa and S. aureus mixed growth, selection of the 
bacterial strains to use was thought to be crucial to accomplish our objective. In this study, we used the P. aeruginosa 
PA14 strain together with the S. aureus Newman strain. This pair of microorganisms has been used in other polymi-
crobial studies15,18,23,24; hence, we considered them suitable for use in our study.
LB, tryptic soy broth (TSB), Dulbecco’s modified Eagle’s medium (DMEM) and synthetic cystic fibrosis spu-
tum medium 2 (SCFM2) were tested as a base to develop a medium that maintains the coexistence and growth of 
both organisms over time. Thus, mixed cultures of PA14 and Newman strains and the respective CFUs were ana-
lyzed after 0, 12, 24, 36 and 48 h of incubation. For PA14-Newman planktonic cultures grown in LB and SCFM2, 
a significant decrease in S. aureus Newman CFUs/mL (p < 0.05) was detected during the initial 24 h of incuba-
tion with no CFUs counted after 24–36 h post-initial inoculation (Fig. 1a,b - LB and SCFM2). In contrast, TSB 
and DMEM maintained S. aureus Newman survival at ~105 CFUs/mL over the 48 h with no significant changes 
detected after 12 h (p > 0.05; Fig. 1c,d - TSB and DMEM). PA14 growth was stable and maintained at ~1010–1011 
CFUs/mL in the different media tested except for SCFM2, in which the strain reached maximal growth at ~109 
CFUs/mL (Fig. 1 - planktonic).
Since P. aeruginosa and S. aureus are commonly found in chronic infections promoted by biofilm formation11, 
this type of growth was examined next. Coculture biofilm growth was assessed in independent 96-well polysty-
rene microtiter plates after 12, 24, 36, 48, 60 and 72 h (Fig. 1 - biofilm). Mixed biofilms grown in LB and SCFM2 
showed similar patterns for PA14 and Newman strains in planktonic growth. However, while Pseudomonas main-
tained a constant number of biofilm-forming CFUs during the 72 h checked, the presence of Newman in the 
mixed biofilm progressively decreased, and by 48 h no S. aureus CFUs were detected in the cocultured biofilm 
(Fig. 1e,f - LB and SCFM2). Similar to the results obtained in the planktonic experiments, coculture growth 
in TSB or DMEM enhanced S. aureus survival in the mixed biofilm. However, while TSB supported Newman 
growth at ~106 CFUs/well for 36 h of incubation, S. aureus survival dropped by 48 h, with no countable CFUs 
detected from that time onward (Fig. 1g - TSB). In contrast, DMEM promoted constant Newman growth (~105–
104 CFUs/well) in the mixed biofilm during the initial 48 h analyzed, with a slight decrease to ~102 CFUs/well after 
60 h of incubation; no countable CFUs were detected only after 72 h (Fig. 1h - DMEM). Although significantly 
increased viability of S. aureus was detected when coculture biofilm was growing in DMEM, percentage numbers 
of the organism within the mixed biofilm did not vary among the media used (Supplementary Table S1). PA14 
levels within the mixed biofilm were similar among the four media tested, with ~107–108 CFUs counted per well 
during the 72 h of the course of the experiment (Fig. 1 - biofilm).
The physiochemical environment where microbes grow can influence the bacterial distribution in the com-
munity3. Furthermore, pH homeostasis is critical to maintaining the integrity of all living cells25,26. Therefore, we 
next thought it important to examine the pH change during the coculture biofilm growth in the different media 
tested. The pH was evaluated at the initial establishment of the biofilms in microtiter plates at 37 °C and after 
24, 48 and 72 h. Differences in pH changes were found depending on if biofilms were grown in monoculture 
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(Supplementary Fig. S1) or coculture (Fig. 2). As shown in Fig. 2, the pH rapidly increased when biofilms were 
grown in LB, SCFM2 or TSB, reaching pH ∼8.7–8.8 by 48 h of incubation when growing in coculture. However, 
in DMEM, the pH was reduced and measured ∼0.5–1 lower, (p < 0.001) compared to that of the other media dur-
ing the 72 h tested. This rapid increase of pH was not observed when both organisms were grown in monoculture 
biofilms (Supplementary Fig. S1). In that case, pH tended to be maintained or acidified (especially for S. aureus 
monoculture biofilms), during the 72 h examined.
Figure 1. Time-course planktonic and biofilm growth of P. aeruginosa PA14 and S. aureus Newman in LB, 
SCFM2, TSB and DMEM. (a-d) log10 CFUs/mL of each bacterial strain during planktonic growth in coculture at 
the time of initial inoculation and after 12, 24, 36 and 48 h of incubation at 37 °C with shaking. (e-h) log10 CFUs/
well of PA14 and Newman strains during coculture biofilm growth on 96-well polystyrene plates over 72 h of 
static incubation at 37 °C. Three independent experiments were performed for both experiments, and error 
bars indicate the standard error of the mean from the representative triplicate. Statistical significance between 
log10 CFUs/mL and between log10 CFUs/well at the different time points is indicated with an asterisk (*p < 0.05; 
**p < 0.01; ***p < 0.001; and ****p < 0.0001).
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Taken together, these results indicate that DMEM has the highest potential to maintain S. aureus survival over 
time when grown together with P. aeruginosa.
Optimizing P. aeruginosa and S. aureus coculture conditions. Several conditions have been described 
to influence P. aeruginosa and S. aureus fitness. Accordingly, we next looked for molecules or additives to sup-
plement the DMEM with the aim of increasing Newman survival in the mixed biofilm. Therefore, nicotinamide 
adenine dinucleotide phosphate (NADPH; 0.2 mM), adenosine monophosphate (AMP; 10 mM), bovine serum 
albumin (BSA; 5% w/v) and L-arginine (L-arg; 0.4% w/v) were chosen to be tested for the ability to compromise 
P. aeruginosa pathogenesis (AMP, BSA and L-arg), influence S. aureus fitness (BSA) and combat oxidative stress 
(NADPH)16,21,27–29.
To evaluate the effect of the different additives, mixed biofilms were grown in independent microtiter plates 
in DMEM supplemented with NADPH, BSA, AMP or L-arg (Fig. 3 and Supplementary Table S2) for 72 h at 
37 °C, and the respective biofilm-forming CFUs were counted on selective agar plates. Generally, no major dif-
ferences were detected in PA14 growth (CFU/well) within the coculture biofilm with any of the additives used 
compared to nonsupplemented DMEM (Fig. 1h - DMEM). Furthermore, P. aeruginosa CFUs/well were ~107–108 
at all time-points and conditions checked (Fig. 3). A different scenario was observed with the S. aureus strain. 
Although all additives tended to maintain stable S. aureus Newman levels of ~106–107 CFUs/well during the 
initial 24 h (Fig. 3), the NADPH- or AMP-supplemented medium (Fig. 3a,c) did not enhance S. aureus growth 
after 36–48 h of incubation compared to nonsupplemented medium and by 60 h, no Newman CFUs were counted 
within the mixed biofilm in these two incubatory conditions. In contrast, coculture incubation in DMEM + BSA 
or DMEM + L-arg promoted sustained S. aureus CFU numbers of ~105–106 during the initial 48 h of the exper-
iment, and these numbers decreased only after 60 h of incubation. Significantly, while in the presence of BSA, S. 
aureus CFUs were ~104 CFUs/well after 72 h of incubation; the L-arg condition showed a gradual decrease in the 
viability of the cocci, with ~102 CFUs/well counted at the end of the experiment (Fig. 3b,d). Remarkably, all addi-
tives increased the S. aureus cell percentage within the mixed biofilm if compared to that calculated in coculture 
biofilms grown in unsupplemented DMEM (Supplementary Table S1), with percentages calculated ~11–25% of 
the total mixed biofilm (Supplementary Table S2).
Oxygen diffusion within PA14-Newman mixed biofilms plays a key role in maintaining bal-
anced bacterial populations. The next step was to evaluate other environmental parameters that could 
influence the coculture biofilm during in vitro growth. Since oxygen competition between P. aeruginosa and 
S. aureus has been described to compromise the viability of the latter in a CF model15, this parameter was next 
assessed in our system.
We next aimed to identify the position inside the well where PA14-Newman biofilm growth occurred and to 
detect possible differences when compared to monoculture biofilm growth. Crystal violet staining of 48 h-old 
biofilms confirmed that the bacterial biofilm growth was limited to the air-liquid interphase (ALI) area of the 
microplate well (Fig. 4a). These results indicate that the CFU values determined in Fig. 3 come from cocultured 
biofilms formed in the ALI area of the microtiter plate. OD570 measurements revealed that PA14 forms a larger 
monoculture than the S. aureus strain. Interestingly, no additive effect was observed in the PA14 biofilm during 
coculture biofilm growth with S. aureus (Supplementary Fig. S2).
To further investigate the role of oxygen during coculture biofilm formation, we changed the in vitro 
microplate model to use coverslips. Thus, to analyze the immersed biofilm growth, the coverslip was placed in the 
bottom of the well of a 6-well plate and completely submerged in the medium. To assess the biofilm growing in the 
ALI area, the coverslip was positioned to line the well wall (see schematic representation in Fig. 4b). Crystal violet 
staining of 48 h-old biofilms revealed no significant differences between immersed biofilms, with similar intense 
violet staining detected between the mono- and cocultured biofilms (Fig. 4c). However, clear differences were 
observed between biofilms grown in the ALI area. While the PA14 monoculture biofilm showed more intense 
violet staining than the Newman monoculture biofilm, greater biofilm coverage of the coverslip was observed 
Figure 2. pH evolution during coculture biofilm growth in different culture media. The plot shows the pH 
measurements of the different supernatant phases of P. aeruginosa PA14 and S. aureus Newman coculture 
biofilms grown in LB, TSB, SCFM2 and DMEM. Measurements were performed at the time of initial 
inoculation (0 h) and after 24, 48 and 72 h of incubation at 37 °C. Statistical significance of the pH measured 
in DMEM at different time points compared to the pH measured in the other media at the same time points is 
denoted with asterisks (***p < 0.001).
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with the S. aureus strain (Fig. 4c). Measurement of the stained biofilms revealed that the Newman monoculture 
biofilm covered ∼7.5 mm of the coverslip, in contrast to the ∼6 mm covered by the PA14 monoculture biofilm. 
An intensive violet-stained band of ∼3 mm was detected in the middle of a greater coverage area of ∼7.5 mm 
when both organisms were grown in unison (Fig. 4c).
Coculture viability was next analyzed to assess the coexistence of both organisms within the mixed bio-
film depending on the proximity to the medium surface during growth. Since increased coculture biofilm was 
obtained in the presence of NADPH, BSA, AMP and L-arg in 96-well plates (Fig. 3), these additives were also 
included in the experiment. After three days of incubation, a greater presence of S. aureus was observed by con-
focal microscopy when biofilms were grown in the ALI area compared to when they were grown completely 
immersed in the medium (Fig. 4d). Increased growth of S. aureus in the ALI area was also confirmed by CFU 
counting (Fig. 4e). In the nonsupplemented DMEM (control) and DMEM + NADPH conditions, the S. aureus 
strain appeared to be dispersed over the glass, whereas in DMEM + BSA, DMEM + AMP and DMEM + L-arg, 
the strain emerged embedded in aggregates within the PA14 biofilm (Fig. 4d - ALI area). In the validation of 
the results obtained in Fig. 3, significantly increased numbers of the Newman strain were counted in the mixed 
biofilms incubated in DMEM including the different additives (Fig. 4d). A different scenario was observed when 
biofilms were grown immersed in the medium, wherein PA14 completely covered the different coverslips, and 
the Newman strain was barely detected (Fig. 4d - Immersed). Only Newman CFUs counted in the mixed biofilm 
grown in DMEM + BSA showed a significant increase relative to the control condition (p < 0.05), although the 
levels were drastically reduced compared to those counted in the ALI area (Fig. 4e). Interestingly, the addition 
of L-arg to the system resulted in a more dispersed PA14 biofilm formation compared to that visualized with the 
other additives (Fig. 4d - L-arg).
Overall, these results confirm that although different additives increase S. aureus survival during mixed bio-
film growth with P. aeruginosa, biofilm formation in the ALI area is fundamental to achieving this enhanced 
survival of S. aureus.
A gradient of dissolved oxygen in the coculture biofilm system explains the differential bacterial 
growth. Different oxygen concentrations across the culture system may explain differential bacterial growth 
within the coculture biofilm. To validate this hypothesis, the dissolved oxygen concentration during biofilm incu-
bation was measured in different areas of interest using an oxygen microsensor system (Fig. 5, Supplementary 
Figure 3. Effect of NADPH, BSA, AMP and L-arg on extending S. aureus survival during coculture biofilm 
growth with P. aeruginosa. Coculture biofilms were grown in vitro on 96-well polystyrene plates for 72 h in 
static conditions at 37 °C. The different graphs show biofilm cells of P. aeruginosa and S. aureus log10 CFUs/well 
during biofilm growth in DMEM supplemented with NADPH at 0.2 mM (a), BSA at 5% w/v (b), AMP at 10 mM 
(c) and L-arg at 0.4% w/v (d) after 12, 24, 36, 48, 60 and 72 h. Conditions were tested in triplicate, and bars 
represent the mean of three independent experiments. The standard error of the mean is included in the plots. 
Significant differences between PA14 and Newman CFUs/well at the different incubation times are indicated by 
asterisks (*p < 0.05; **p < 0.01; ***p < 0.001; and ****p < 0.0001).
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Fig. S3). Thus, the oxygen consumption rates in the area immediately above the immersed biofilm (ALI area) 
and in the medium surface (top position) were measured and analyzed over time (Fig. 5a). Additionally, a spatial 
oxygen profile was also measured in the medium immediately after the bottom area became depleted of oxygen 
(Fig. 5b). The microsensor measurements reflected a gradual decrease in the oxygen content from ∼5.5 (∼80% of 
the dissolved oxygen) to ∼0 mg/L in the initial ∼80 min when the PA14-Newman combined biofilm was growing 
completely immersed in the medium (Fig. 5a, green line). However, sensor placement in the ALI area (Fig. 5a, red 
line) confirmed a maintained oxygen concentration of ∼5.5 mg/L during these initial 80 min. Progressive oxygen 
consumption was detected after that time point, reaching ∼1 mg/L (∼20% of the dissolved oxygen) by ∼110 min 
from the initial incubation. Interestingly, the oxygen concentration was sustained at ∼1 mg/L for approximately 
∼50 additional minutes before decreasing to ∼0.5 mg/L (∼6% of the dissolved oxygen). The oxygen levels were 
then maintained at ∼0.5 mg/L without reaching complete depletion. A different result was obtained when the 
sensor was placed close to the medium surface (top position; Fig. 5a-blue line). In this position, and comparable 
to the ALI area, a sustained concentration of ∼5.5 mg/L was measured during the initial 80 min of incubation. 
However, in this case, a linear oxygen decrease occurred immediately after that time point, reaching 0 mg/L after 
∼125 min (Fig. 5a). Analysis of the oxygen stratification at different depths revealed that most of the medium 
in which the coculture biofilm was growing was oxygen-free. This area showed 0 mg/mL oxygen and accounted 
for the initial ∼3 mm of the medium depth. Only the area closest to the surface, the first ∼1 mm, revealed oxy-
gen content and showed a progressive increase that reached ∼6.5 mg/L (∼95% of the dissolved oxygen) at the 
medium surface (Fig. 5b).
Figure 4. Balanced P. aeruginosa PA14 and S. aureus Newman populations growing in a coculture biofilm 
is dependent on the air availability. Total PA14 and Newman biomass grown in monoculture or coculture 
biofilms and stained with crystal violet. (a) Pictures show the biofilm growth of monoculture and coculture 
biofilms in the air-liquid interphase area (ALI area) of a 96-well plate. A zoomed image highlighting a region of 
interest of each biofilm is included in the figure. (b) Schematic representation of the coverslip position within 
the well during incubation of the PA14-Newman coculture biofilm immersed in the medium or in the ALI 
area. (c) Biofilm biomass staining of PA14 and Newman mono- and coculture biofilm growth over a coverslip 
immersed or in the ALI area. The length of the stained area in the coverslip is included on the plot. (d,e) PA14-
Newman coculture biofilms grown in the ALI area or immersed in DMEM (control) and DMEM + NADPH, 
BSA, AMP and L-arg. (d) Confocal images of the mixed biofilms at the different time points were taken at 63X 
magnification, PA14 is shown in blue (DAPI) and Newman in green (CFTM-488A). A representative image of 
each biofilm from three independent experiments. (e) Plots show the different log10 value of PA14 and Newman 
CFUs covering each coverslip after 3 days of incubation. The results show the mean of three independent 
experiments with the corresponding standard error of the mean. Statistical significance (p < 0.05) compared to 
the relative bacterial control condition is indicated by an asterisk (*) over each bar.
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These results may suggest that, given the proximity to the surface, the ALI area would not reach oxygen deple-
tion and would be able to maintain some oxygen content even though it would be a low percentage of the dis-
solved oxygen.
DMeM supports P. aeruginosa and S. aureus balanced coculture biofilm growth and stabilization 
over time. To reinforce the potential of our developed DMEM culture conditions in forming and preserving 
P. aeruginosa-S. aureus mixed biofilms, we established a continuous-flow biofilm. Continuous-flow biofilms are 
the closest approximation known for the growth of biofilms with similar physical, chemical and biological heter-
ogeneity as those naturally formed in vivo30.
After three days of continuous flow, we confirmed that only DMEM was able to sustain stable growth of both 
populations in the biofilm. Mixed biofilms grown in TSB (Fig. 6a) or TSB supplemented with BSA (Fig. 6b) did 
not show any growth or increase in S. aureus survival within the coculture system compared to those in DMEM 
(Fig. 6c,d,f). Biomass evaluation using the COMSTAT 2 software determined that when the experiment was 
performed in TSB, P. aeruginosa accounted for ∼90% of the coculture biofilm, while S. aureus accounted for 
only ∼10% of the system. The addition of BSA to TSB barely increased S. aureus growth, and its presence in the 
coculture biofilm was calculated to be ∼15% in this incubatory condition (Fig. 6f). However, coculture biofilms 
grown in DMEM or DMEM + BSA revealed an increased presence of S. aureus when they were visualized with 
a confocal microscope (Fig. 6c,d). In general, we observed that both strains did not grow mixed together but 
independently and well distributed in the flow-cell channel. Interestingly, while microcolonies of S. aureus were 
detected growing embedded in the PA14 biofilm in unsupplemented DMEM (Fig. 6c), a thick and compact layer 
of S. aureus was visualized covering the P. aeruginosa biofilm when BSA was added to the flow system (Fig. 6d). 
COMSTAT 2 software revealed that this dense layer of Newman biofilm had an average thickness of ∼12.50 μm, 
whereas the P. aeruginosa biofilm growing the beneath S. aureus was ∼6.73 μm thick.
The orthogonal views, 3D representations and evaluation of the different regions of interest (ROIs) of the 
coculture biofilms were next analyzed to assess how bacterial populations were distributed within the mixed bio-
film system. Our experimental approach confirmed the presence of S. aureus microcolonies growing in clusters 
within PA14 biofilms during growth with DMEM (Fig. 6c). Two schematic drawings are presented in Fig. 6e to 
clearly show how bacterial populations are distributed within the coculture biofilm during growth in DMEM and 
DMEM + BSA. Enumeration of these microcolonies revealed an average growth of approximately 65–90 of cells 
per bacterial aggregate, with a maximum count of approximately ∼150 of Newman cells (Supplementary Fig. S4). 
These image analyses also verified that S. aureus biofilm growth occurred on top of the P. aeruginosa biofilm, 
which was particularly evident during incubation with DMEM + BSA (Fig. 6d,e). These results are in agreement 
with those presented in Fig. 4. Therefore, both bacterial species maintain separate growth and distribution in 
coculture biofilms. Biomass evaluation revealed balanced growth of both bacterial populations of ∼35% and 
∼65% for Newman and PA14, respectively, during incubation in DMEM (Fig. 6f). However, and confirming the 
confocal microscopy observations, a greater percentage of the S. aureus Newman population was measured in 
DMEM + BSA, accounting for ∼70% of the total coculture system (Fig. 6f).
The continuous-flow biofilm confirmed that DMEM favors the coexistence of P. aeruginosa and S. aureus in 
mixed biofilms. Furthermore, we also detected how the addition of BSA changed the architecture of the biofilm 
by increasing S. aureus proliferation and identified different spatial distributions of the strains in the biofilm.
Figure 5. Differences in oxygen concentration depending on the position in the well where PA14 and Newman 
are cocultured and growing. Dissolved oxygen concentration (DO) was determined in the different areas of 
interest in the PA14 and Newman in vitro coculture biofilm model. (a) Plot shows the DO (mg/L; ppm) given 
by the optical fiber microsensor, depending on the position placed in the coculture system: top, immersed and 
in the ALI area. A schematic showing the approximate position of each measurement is included in the plot. 
The equivalence of significant DO values to the percentage of dissolved oxygen saturation (gray numbers) is 
provided as a reference. (b) DO at different depths of the culture well after the immersed area reached a DO of 
0 mg/L (approximately 85 min of incubation). An interpretation of the oxygenation states across the different 
layers is provided on the right: 1, humid air (the oxygen value is a result of the saturation of the sensor); 2, 
oxygenated interphase; and 3, anaerobic culture.
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Figure 6. Balanced and stable P. aeruginosa PA14 and S. aureus Newman strain populations within a three-day-
old mixed biofilm grown in continuous flow. PA14 and Newman were grown simultaneously in a continuous-
flow biofilm in TSB (a), TSB + BSA (b), DMEM (c) and DMEM + BSA (d) for three days. At the indicated time 
point, the biomass growing over the different channels was stained with DAPI (blue, PA14) and CFTM-488A 
(green, Newman) and visualized using confocal microscopy. The figure shows the composite of the sum of the 
slices (Z Stack), with the respective orthogonal views, and the 3D representation of each mixed biofilm formed 
using both ImageJ and ZEN software. Mixed biofilms were tested in triplicate, and a representative image from 
those taken at magnifications of 40X and 63X is shown. A region of interest (ROI), including the different 
microscope projections and representations, is also presented in the figure. Red arrows indicate PA14 and 
Newman strains within the mixed biofilm. (e) Schematic representations of the cocultured biofilm depending 
on growth in DMEM or DMEM + BSA from the previous confocal microscope Z-stacks and orthogonal views. 
P. aeruginosa is represented in blue, and S. aureus is represented in green. (f) Table shows the percentage of blue 
Pseudomonas and green Staphylococcus present in the different cocultured biofilms calculated from an average 
of 5–15 different microscope stacks using the COMSTAT 2 and ImageJ software.
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Oxygen stratification within the coculture biofilm is a key modulator of PA14 and Newman coexistence. 
We next wanted to verify the existence of an oxygen-stratified environment in the continuous-flow biofilm that 
may influence S. aureus survival and stable growth alongside P. aeruginosa. Oxygen diffusion within the biofilm 
was evaluated with the assumption that fresh and oxygenated medium was added continuously in the system 
(∼6.5 mg/mL oxygen measured with the oxygen microsensor).
Orthogonal views of the coculture biofilm grown in the flow-cell channel confirmed the clear distribution of 
the S. aureus biofilm on top of P. aeruginosa in the area closest to the medium surface (Fig. 7a). Consequently, 
we next wanted to validate the presence of an oxygen gradient that could be crucial for Newman survival in the 
mixed biofilm, and a key modulator of the bacterial distribution detected. To probe different oxygen concentra-
tions within the coculture system, the continuous-flow biofilm was analyzed using the Hypoxia Probe dye. The 
key attribute of this dye is that its fluorescence is quenched by oxygen, so the lower the oxygen concentration is, 
the greater the red fluorescence signal emitted by the stained cells, thus allowing the detection of an anaerobic 
Figure 7. Oxygen stratification within the cocultured biofilm determines the spatial distribution of P. 
aeruginosa and S. aureus and their coexistence. (a) XZ-orthogonal view of a P. aeruginosa and S. aureus 
coculture biofilm grown in DMEM + BSA (see Fig. 6d). The image shows the separate position of Newman and 
PA14 within the ∼16 μm-biofilm and the possible oxygen gradient present in the system. (b) Graph shows the 
average pixel intensities of PA14 (blue) and Newman (Green) biomasses (plotted on the upper Y-axis) compared 
to the oxygen-related red intensity (plotted on the lower Y-axis) along the different thicknesses (μm) of a 3-day-
old cocultured biofilm in flow. Pixel intensity averages were calculated from ten different images using ImageJ 
software. Included in the figure, is a sequential set of micrographs showing the red fluorescence emission given 
by the hypoxia probe through the different biofilm layers, indicating the oxygen stratification present along the 
thickness of the continuous-flow cocultured biofilm. Intense red emission relates to the hypoxic environment 
through the different biofilm depths (μm), from the bottom to the surface, additionally indicated with a 
schematic of the oxygen gradient present in the system.
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environment. Red-light emission (hypoxia) through the different layers of the coculture biofilm confirmed the 
bright fluorescence during the initial ∼4 μm of biofilm thickness that gradually decreased across the bacterial 
community. Red fluorescence was barely detected in the more superficial biofilm layers, thus confirming aerobic 
conditions in that area (Fig. 7b). Additionally, pixel intensity analysis of the hypoxic region (red) corroborated 
that red emission peaked around the initial ∼2 μm of the biofilm depth. Furthermore, the PA14-Newman bio-
mass was also quantified in this continuous-flow biofilm. P. aeruginosa PA14 (blue) displayed a maximum peak 
intensity at ∼3 μm of the biofilm depth, corresponding to the more anaerobic region of the biofilm, with fluo-
rescence extending to a thickness of ∼10 μm. S. aureus Newman (green) clearly showed a pixel intensity curve 
shifted to higher and more oxygenic biofilm layers (Fig. 7b). Green intensity measurements confirmed that S. 
aureus was barely detectable in the initial ∼3 μm of the mixed biofilm (coinciding with the anoxic part of the bio-
film); the intensity increased, achieving a maximum and extended peak at ∼6–9 μm of depth, with fluorescence 
emission extending to ∼14–10 μm of the biofilm thickness.
Taken together, these results demonstrate that the coculture biofilm formed in continuous flow also displays 
oxygen stratification across the different biofilm layers. P. aeruginosa growth occurred across the deepest layers of 
the biofilm, where less oxygen content was detected, while S. aureus biofilm growth was quantified closer to the 
biofilm surface, corresponding to the most oxygenated area.
Antibiotic resistance of P. aeruginosa and S. aureus is critically increased during coculture biofilm 
growth. Biofilm-associated infections have historically been treated as single-species events. Nevertheless, 
some of these infections are now known to be composed of multiple combinations of bacteria, involving complex 
interactions that can influence their fitness and antibiotic tolerance2,4. The demonstration of altered antibiotic 
susceptibilities of PA14 and Newman when grown in coculture biofilms was thought to be necessary to validate 
the combination of coculture conditions and environmental prerequisites identified in this study. Even though in 
DMEM + BSA condition presence of S. aureus within the mixed biofilm grown in microtiter plates was detected 
also after 72 h of coculture growth, we chose to evaluate the antimicrobial tolerance after 48 h since according to 
Fig. 3b, at that time-point Newman’s CFUs in the coculture biofilm were counted ∼100−fold higher than at 72 h. 
Hence, 48 h-old PA14 and Newman mono- and coculture biofilms were treated with ciprofloxacin (Cpx) and gen-
tamicin (Gm). The respective biofilm-forming CFUs were subsequently counted on selective agar. The antibiotics 
and the range of concentrations used were chosen according to their reported minimal inhibitory concentra-
tions (MICs) and their usage in treating both bacterial infections4,31. The experiment was performed in a 96-well 
microtiter plate and included BSA since it was the additive that showed the greatest potential for maintaining the 
stable growth of both bacterial populations in vitro.
Bacterial CFUs that remained viable within the mono- and the coculture biofilms after the antibiotic treatment 
were enumerated (Supplementary Table S3), and the percentages of viable CFUs that persisted in each biofilm 
after the different treatments, compared to each untreated biofilm, were subsequently calculated (Fig. 8). The 
Minimum Biofilm Eradication Concentration (MBEC) of each antibiotic against P. aeruginosa and S. aureus 
mono and coculture biofilms was also calculated (Table 1). Crystal violet staining of control wells confirmed that 
the mature biofilm grew in the ALI area of the well (data not shown). A similar behavioral pattern was observed 
in both organisms after the respective antibiotic treatments; however, S. aureus revealed a much greater benefit of 
growing in coculture than P. aeruginosa, since its viability during both treatments increased exponentially when 
grown in coculture with P. aeruginosa. As for P. aeruginosa, the bacterium exhibited ∼38-, ∼68- and ∼390-fold 
higher tolerance to Gm treatment in coculture than in monoculture biofilm growth for concentrations of 0.5, 1 
and 2 μg/mL, respectively, (Fig. 8a - graph PA14%) and ∼7- and ∼27.5-fold increased to Cpx treatment used at 
concentrations of 0.5 and 1 μg/mL (Fig. 8b - graph PA14%). The MBEC determinations (Table 1) confirmed that 
Gm treatment at ≥0.5 and ≥4 μg/mL and Cpx treatment at ≥0.5 and ≥2 μg/mL cleared PA14 from the mono- 
and coculture biofilms, respectively (Fig. 8a,b -graph PA14%). The percentage calculations revealed that growing 
S. aureus in coculture enhanced its capacity to persist in the presence of Gm >1000-fold, at a concentration of 
0.5 μg/mL, and >470-fold at 1 μg/mL (Fig. 8a - graph Newman%). A similar pattern was detected for Cpx treat-
ment; within a coculture biofilm with P. aeruginosa, the viability of Staphylococcus increased ∼400-fold when the 
antibiotic was used at 0.5 μg/mL and >468-fold when it was used at 1 μg/mL (Fig. 8b - graph Newman%). Only 
doses ≥2 μg/mL of Gm or Cpx cleared S. aureus from the mixed biofilm. In contrast, treatments with 0.5 μg/mL 
with any of the antibiotics used was sufficient to clear S. aureus from a 48 h-old monoculture biofilm (Fig. 8a,b 
- graph Newman% and Table 1). When these high concentrations were used, the viability of the S. aureus strain 
was drastically reduced.
Comparisons between the percentages of the viable P. aeruginosa and S. aureus CFUs in the coculture biofilm 
after the antibiotic treatments to those calculated in the monoculture biofilms revealed significance in all cases 
(p < 0.001). These results confirm the increased antibiotic tolerance of P. aeruginosa PA14 and S. aureus Newman 
strains when grown in a mixed biofilm rather than in a monoculture biofilm, thus validating the coculture con-
ditions established in this study.
Discussion
Biofilm-associated infections are currently a critical worldwide threat32–34. The increasing emergence of 
antimicrobial-resistant bacteria and the knowledge that some of these infections are polymicrobial challenge the 
antimicrobial chemotherapy to administrate and aggravates the disease outcome2,35,36. P. aeruginosa and S. aureus 
are two major pathogens commonly found growing together in intricate biofilms in disease-affected lungs11 
or wounds13. Herein, we have unraveled the potential of DMEM to sustain a P. aeruginosa PA14 and S. aureus 
Newman combined biofilm for up to three days in vitro and identified BSA as a valuable and critical additive that 
significantly increases S. aureus survival and growth in the coculture system. Remarkably, we also demonstrated 
the importance of continuous oxygen diffusion in limiting S. aureus survival and keeping the growth of both 
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bacterial populations balanced, highly influencing their distribution in the coculture biofilm. Furthermore, using 
our developed coculture conditions, we confirmed that the antimicrobial susceptibilities of P. aeruginosa and S. 
aureus differ depending on whether they are growing in monoculture or coculture in biofilms.
Among the different media evaluated (LB, TSB and SCFM2), DMEM was the greatest at controlling S. aureus 
survival during simultaneous growth (planktonic and biofilm) with P. aeruginosa. DMEM is a rich culture medium 
used in routine cell culture experiments, which contains numerous amino acids, vitamins, and inorganic salts, 
among other components37. Remarkably, the D-glucose concentration in this medium is ∼17.5 mM, which is greater 
than the usual 0.2% (∼11.1 mM) added to LB or TSB medium in routinely used biofilm formation protocols38–40, 
or the 3 mM present in the SCFM2 medium41. In healthy people, glucose concentration in the airway surface 
Figure 8. P. aeruginosa PA14 and S. aureus Newman coculture biofilms induce enhanced tolerance to antibiotic 
treatment compared to monoculture biofilms. After 48 h, matured mono- and cocultured PA14 and Newman 
biofilms grown in microtiter plates were treated with 0.5, 1.0, 2.0, 4.0 and 8.0 μg/mL gentamicin (a) and 0.5, 1.0, 
2.0, and 4.0 μg/mL ciprofloxacin (b) for 15 h. Symbols in the plots represent the remaining percentage of CFUs 
of each strain in the biofilm after different antibiotic treatments compared to the relative untreated biofilm. 
Each graph shows the percentages of PA14 and Newman CFUs compared according to whether the biofilms 
were grown in mono- or coculture. Percentages were calculated according to the bacterial CFUs counted on 
selective agar plates after different antimicrobial treatments (Supplementary Table S3). Analysis of the statistical 
significance between the calculated percentages of bacterial CFUs that remained in the cocultured biofilm 
(after each antibiotic treatment) and those calculated in the monocultured biofilms revealed significance with 
p < 0.0001 in all cases.
MBEC (µg/mL) Biofilm reduction
Gentamicin
PA14 monoculture 0.5 ≥99%
PA14 coculture 4 ≥99%
Newman monoculture 0.5 ≥99%
Newman coculture 2 ≥99%
Ciprofloxacin
PA14 monoculture 0.5 ≥99%
PA14 coculture 2 ≥99%
Newman monoculture 0.5 ≥99%
Newman coculture 2 ≥99%
Table 1. MBEC values of gentamicin and ciprofloxacin antibiotics against P. aeruginosa PA14 and S. aureus 
Newman in monoculture or coculture biofilms.
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liquid (ASL) is ∼0.4 mM, 12 times lower than blood glucose42,43. However, lung inflammation, caused by diseases 
such as CF or chronic airway inflammation, increases glucose flux through the epithelial cell membrane, raising 
∼10–12 times the glucose concentration in the ASL. Different studies have described how increased glucose levels 
in ASL promote bacterial lung infection42,44,45. Furthermore, diabetes affected-people have wound healing issues 
and increased risk of infection due to an impaired host defence46. Glucose is not the preferred carbon source of P. 
aeruginosa47 but is the preferred carbon source of S. aureus, which exhibits preferential uptake of this sugar, espe-
cially during infection48. Therefore, it is plausible to hypothesize that S. aureus could benefit from the high glucose 
concentration in DMEM and grow without competition for the substrate. Additionally, a differential planktonic 
growth pattern was detected in S. aureus Newman depending on whether the bacterium was grown in DMEM or 
TSB (Supplementary Fig. S5). In DMEM, S. aureus grew rapidly and achieved late-exponential/stationary phase, 
with growth maintained during the course of the experiment. However, in TSB, the strain exhibited the usual 
bacterial growth curve with lag, exponential and stationary phases. This result indicates increased efficiency of S. 
aureus growth in DMEM, especially during the initial stage of growth, which we hypothesize could be beneficial 
during simultaneous biofilm growth with P. aeruginosa to rapidly form a microcolony after initial attachment, 
thus providing defense against Pseudomonas49. S. aureus growth in firmly packed microcolonies during coculture 
biofilm growth with P. aeruginosa PAO1 has been previously seen by Yang and coworkers50. In our study, this 
microcolony formation may also be facilitated by the increased concentration of NaCl present in the DMEM for-
mulation (∼120 mM), which is >3-fold higher than in LB, TSB or SCFM2 and has been seen to stimulate biofilm 
aggregation and growth51,52. The concentration of glutamine present in DMEM (∼2.5 mM) may also affect the 
coexistence of both microorganisms by diminishing the specific competition for this amino acid, as a nitrogen 
and energy source, which has been recently reported to occur early during coculture53.
Significantly, DMEM contains HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid; ∼15 mM), 
which is considered a “good buffer” for its limited effect on biochemical reactions and for being chemically and 
enzymatically stable, among other properties54. The buffering properties of HEPES were evident in the growing 
coculture biofilms, and the pH rise was dampened compared to that measured in the other media (Fig. 2). pH 
homeostasis is critical to maintaining the integrity of cytoplasmic proteins in all living cells, and their optimal 
pH fluctuates in a narrow range of 7.4–7.825,26. Although SCFM2 contains 3-morpholinopropanesulfonic acid, it 
failed to maintain the pH levels in the coculture. This synthetic CF medium was developed based on CF sputum 
that contained high concentrations of P. aeruginosa41, which may explain why SCFM2 did not support S. aureus 
viability in the system. Additionally, a factor increasing the perturbation of P. aeruginosa and S. aureus coexist-
ence in this fluctuating pH environment is the production of different proteases by P. aeruginosa in an alkaline 
environment of pH ∼8. In particular, the P. aeruginosa staphylolytic protease LasA possesses optimal activity at 
approximately pH 8.555–57.
DMEM supplementation with BSA and L-arginine increased S. aureus viability throughout the 72 h of 
coculture biofilm growth with P. aeruginosa. Although coculturing the biofilm in DMEM + L-arg increased the 
Newman biofilm-forming CFUs, confocal microscopy revealed an altered coculture biofilm architecture, with 
disaggregated clumps covering the coverslip (Fig. 4d), which is consistent with the phenotype promoted by 
L-arginine that has been seen in other biofilm communities58–60. Thus, we conclude that among the additives 
tested, BSA possesses the greatest potential to increase S. aureus viability and maintain the population balance 
in a well-engineered coculture biofilm with P. aeruginosa. Subsequent experiments in flow-cell biofilms corrobo-
rated the effect of BSA in increasing S. aureus survival and growth during mixed biofilm formation with P. aerug-
inosa (Fig. 6d). Although albumin has been described to diminish P. aeruginosa killing of S. aureus in wounds 
by binding and sequestering Pseudomonas quorum sensing molecules21, which is also likely what occurred in 
our model, we also believe albumin has a direct effect on S. aureus viability, although further experiments are 
needed to confirm this hypothesis. Albumin is the main plasma protein and a carrier of numerous molecules, 
such as metals and other ions, bilirubin, amino acids, fatty acids, enzymes, and hormones61. With an unknown 
mechanism, it is known that the presence of this protein in the culture medium enhances S. aureus growth expo-
nentially, possibly by scavenging traces of protein-bound nutrients62–64. Therefore, we suggest that albumin could 
play a direct role in inducing prompt microcolony formation by increasing the proliferation rate of S. aureus 
in a hostile environment with P. aeruginosa. Furthermore, although expression of different virulence factors of 
Pseudomonas has detected increased during coculture growth with S. aureus (e.g. LasA protease or pyocyanin 
production)53, some staphylococcal factors (e.g. the Panton-Valentin leukocidin protein) have been also observed 
during these coculture conditions, which may be playing a role also in competing with the Pseudomonas65.
Remarkably, in this study, we demonstrate an important role for oxygen in achieving continuous and stable 
coculture biofilms of P. aeruginosa and S. aureus. We also observed a differential distribution of the bacterial 
populations depending on the oxygen content in the surrounding environment. Lungs are not entirely aerobic, 
especially those affected by CF, in which the thick mucus present in the airways generates diverse oxygen content 
between pulmonary regions, thus enhancing the heterogeneity of microbes able to proliferate and persist at the 
same site66–68. Oxygen diffusion also mediates the different spatial distribution of bacteria in wounds; hence, P. 
aeruginosa has been found deeper in the tissue than S. aureus, which grows predominantly at the wound surface13. 
Pseudomonas is able to grow in anaerobic conditions in the presence of nitrates, which are included in the DMEM 
formulation. S. aureus encodes a set of genes required for growth either aerobically or anaerobically69,70; however, 
aerobic respiration is preferred by S. aureus during monoculture growth. Despite these metabolic preferences, 
during simultaneous growth with P. aeruginosa, oxygen competition between organisms drives S. aureus to shift 
to fermentative metabolism. This metabolic shift is also triggered by the expression of siderophores, phenazines 
and other exoproducts (i.e., 2-heptyl-4-hydroxyquinoline N-oxide (HQNO) production) by Pseudomonas that 
compromise S. aureus viability15,71. In our model, increased S. aureus Newman survival was detected when the 
coculture biofilms were grown in the ALI area, either in a 96-well plate or over coverslips, rather than during com-
plete medium immersion. Furthermore, we confirmed the existence of an oxygen gradient across the medium 
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depth during biofilm growth, with a continuous micro-oxygenated phase at the medium surface (corresponding 
to the ALI area). Therefore, we hypothesize that persistent oxygen diffusion at the ALI area of the coculture sys-
tem increases S. aureus survival within the mixed biofilm by diminishing the oxygen competition between the 
organisms and the subsequent production of P. aeruginosa molecules that eventually kill S. aureus.
The public health concern about biofilm-associated diseases is linked to the altered antimicrobial susceptibili-
ties that these communities present36. Unoptimized therapies and variations in the antibiotic concentration across 
the biofilm layers promote the development of resistance since bacteria are usually exposed to subinhibitory 
concentrations of the antimicrobial4. Exacerbating the problem is the fact that these biofilms tend to be composed 
of multiple species, with different fitness values and high levels of cooperative and synergistic interactions that 
are often detrimental to the host2,4. For instance, the simple addition of P. aeruginosa supernatant to S. aureus 
Newman biofilms has been seen to be sufficient to increase the tolerance of S. aureus to a wide range of antibi-
otics, such as vancomycin, tobramycin and oxacillin18. Furthermore, it has been seen that continuous exposure 
of S. aureus to P. aeruginosa HQNO promotes the formation of antibiotic-resistant small colony variants of the 
bacterium, enhancing its resistance to aminoglycosides23. P. aeruginosa and S. aureus showed enhanced toler-
ance to gentamicin and ciprofloxacin antibiotics when they were grown in coculture biofilms (Fig. 8). Hence, we 
believe that the use of the conditions revealed in this study allows the stable formation of P. aeruginosa PA14 and 
S. aureus Newman coculture biofilms involving the intricate and interspecific relations responsible for influencing 
the antimicrobial tolerance of each strain.
In summary, in this study, we elucidated the potential of DMEM for P. aeruginosa and S. aureus in vitro cocul-
ture. Additionally, we have discovered that supplementing DMEM with BSA and providing continuous oxygen 
diffusion allows the formation of a mature mixed biofilm with stable populations of P. aeruginosa and S. aureus. 
This study provides useful insights about the establishment of a P. aeruginosa and S. aureus combined biofilm in 
vitro, which we believe would be of help for the study of phenotypes derived from this clinically challenging bac-
terial cooperation as well as for optimizing the antimicrobial therapy used to treat these infections.
Methods
Bacterial strains and growth conditions. Pseudomonas aeruginosa PA14 wild type72 and Staphylococcus 
aureus Newman (ATCC 13420) were used throughout this study, although S. aureus ATCC 12600 and ATCC 
29213 were also initially tested. Overnight cultures (O/N) were performed aerobically at 37 °C in Luria-Bertani 
medium (LB; Scharlab, S.L., Barcelona, Spain) and in tryptic soy broth (TSB; Scharlab, S.L.) for the PA14 and 
Newman strains, respectively.
P. aeruginosa PA14 and S. aureus Newman coculture medium conditions. LB, TSB, synthetic 
cystic fibrosis sputum medium 2 (SCFM2), prepared as previously described41, and Dulbecco’s modified Eagle’s 
medium/nutrient mixture F-12 (DMEM; Thermo Fisher Scientific, Waltham, Massachussetts) were tested. When 
required, reduced nicotinamide adenine dinucleotide phosphate (NADPH; 0.2 mM), adenosine monophosphate 
(AMP; 10 mM), bovine serum albumin (BSA; 5% w/v) and L-arginine (0.4% w/v) were added to the medium. 
O/N cultures of PA14 and Newman strains were washed twice with 1X phosphate-buffered saline (PBS, pH = 7.4). 
To prepare the initial mixed bacterial suspension, each strain was inoculated at a final optical density λ = 550 nm 
(OD550) of 0.05 for planktonic experiments, and an OD550 of 0.10 for biofilm experiments.
Planktonic coculture growth. Mixed bacterial suspensions in a final volume of 20 mL were incubated 
aerobically at 37 °C with vigorous shaking (200 rpm). At given time points, each planktonic culture was serially 
diluted in 1X PBS and plated on LB agar (Scharlab, S.L.) to count P. aeruginosa CFUs, and tryptic soy agar (TSA; 
Scharlab, S.L.) supplemented with 7.5% (w/v) NaCl to selectively count S. aureus CFUs73.
Coculture biofilm growth under static conditions. Static P. aeruginosa PA14-S. aureus Newman mixed 
biofilm growth was tested on (i) plastic and (ii) glass surfaces:
 (i) Plastic surface: 200 μl of each mixed bacterial suspension was inoculated in triplicate in 96-well polysty-
rene plates with a flat bottom (Corning; Sigma-Aldrich, San Luis, Missouri) and incubated at 37 °C without 
shaking. At different time points, the planktonic phase was removed, and each well was washed three times 
with 1X PBS. The biofilm phase formed over the wall of each well was removed using a pipette tip, and 
the triplicates were mixed together. For CFU quantification, each biofilm cell suspension was placed in an 
ultrasonic bath (USC100T, VWR) for 5 min and subsequently vortexed for 30 seconds, to help dispersing 
the biofilm. Bacterial suspensions were then serially diluted in 1X PBS and plated on selective agar as 
described for planktonic growth. Separately, the biofilm mass formed inside the well was stained with 0.1% 
(w/v) crystal violet, and the biomass (OD570) was determined as previously described74.
 (ii) Glass surface: 18 × 18 mm coverslips (Menzel-Gläser, Thermo Fisher Scientific) were placed in a 
6-well polystyrene plate with lid (Dd biolab, Barcelona, Spain), and each well was filled with 3 mL of the 
PA14-Newman bacterial suspension. The coverslip was positioned completely immersed in the bacterial 
suspension or only half immersed. The half immersion, with the air-liquid interphase (ALI) area, was 
achieved by placing the coverslip at a ∼45° angle against the wall of the well (see Fig. 4b). Unattached cells 
were removed after three hours of incubation, and 3 mL of fresh medium was subsequently added again. 
This procedure was repeated every 12 h during the course of the experiment. At the given time points, the 
coverslip, covered with the established mixed biofilm, was gently washed with PBS. To determine bacterial 
CFUs, biofilm-forming cells were scraped off the coverslip, and serial dilutions were plated on selective 
agar plates as described above. In addition, the biomass of the PBS-washed coverslip was stained with 
crystal violet or with different dyes for confocal microscopy as described below.
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pH measurements. The pH of the supernatant phase of each PA14 and Newman monoculture and coculture 
biofilm was measured using a GLP 21 pH meter (Crison®, Hospitalet de Llobregat, Barcelona). For this exper-
iment, biofilms were grown in a volume of 3 mL in 6-well polystyrene plates. pH measurements were taken in 
triplicate for each culture medium and time point, directly in the microplate well where the biofilm was growing.
Confocal laser scanning microscopy and image analysis. To differentially stain P. aeruginosa PA14 
and S. aureus Newman, a Bacterial Viability and Gram Stain kit (Biotium, Fremont, California) was used fol-
lowing the manufacturer’s instructions. This kit uses the cell membrane differences between gram-negative and 
gram-positive bacteria to differentially stain each species. Briefly, the kit combines DAPI to stain the bacterial 
DNA blue with CFTM-488A-wheat germ agglutinin (WGA) to bind, specifically, the N-acetylglucosamine present 
in the peptidoglycan of the cell wall in gram-positive bacteria. Consequently, P. aeruginosa PA14 will be stained 
blue, and S. aureus Newman will be stained green. To detect bacterial cells growing in different oxygen concen-
trations, we used the phosphorescent light-emitting iridium complex Hypoxia Probe (Organogenix; Bionova 
científica, Barcelona, Spain) according to the manufacturer’s instructions.
Stained bacteria were imaged using a Zeiss LSM 800 confocal laser scanning microscope (CSLM, Zeiss, 
Oberkochen, Germany), and images were analyzed with ImageJ and ZEN (Zeiss software).
Assessment of the oxygen concentration in the coculture system. The coculture biofilm was estab-
lished as described above but using lids for the 6-well plates with small holes drilled in the desired locations. 
After the addition of fresh medium, the plate was transferred to equipment for oxygen measurement described 
in Supplementary Fig. S3. The dissolved oxygen was measured using an Oxymicro Fiber-Optic Sensor System 
(World Precision Instruments) connected to a micro-optode oxygen sensor in a syringe-type housing (PreSens, 
Regensburg, Germany); the needle of the housing crossed the lid of the plate, and the optical fiber was placed 
using the plunger at the desired location. All measurements were compensated with temperature using a temper-
ature probe placed directly above the culture plate.
Micro-optodes were calibrated using temperature-compensated measurements of water saturated with air 
(100% air saturation, 8.25 mg/L at 25 °C and 1 atm) and a 10 g/L solution of sodium dithionite (0% O2).
Coculture biofilm incubated in a continuous-flow system. The P. aeruginosa and S. aureus mixed 
bacterial suspension (each strain at OD550 = 0.10) was inoculated in a three-channel flow-cell (DTU Systems 
biology, Technical University of Denmark). Media was pumped at a constant flow rate of 42 μl per minute and 
channel using an Ismatec ISM 943 pump (Ismatec, Wertheim, Germany), as previously described75. After 3 
days of growth, biofilms were stained with the Bacterial Viability and Gram Stain kit or with the Hypoxia Probe 
and observed by confocal microscopy. Images were generated, and biomass was calculated using ImageJ and 
COMSTAT 2 software75. Percentage of S. aureus in the coculture biofilm was calculated taking the pixels given 
by S. aureus-CFTM-488A (channel 0) from the pixels given by the total DAPI staining (channel 1). P. aeruginosa 
percentage in the coculture biofilm was subsequently obtained by subtracting the percentage of S. aureus coverage 
from the total biofilm (100%).
Antimicrobial treatments and minimum biofilm eradication concentration (MBEC) calculations. 
P. aeruginosa PA14 and S. aureus Newman 48 h coculture biofilms in 96-well polystyrene plates were treated with 
gentamicin sulfate (Panreac AppliChem, Castellar del Vallès, Spain) at concentrations of 0.5, 1, 2, 4 and 8 μg/
mL and with ciprofloxacin hydrochloride (Cayman Chemical, Ann Arbor, Michigan) at 0.5, 1, 2 and 4 μg/mL to 
investigate possible alterations on antibiotic tolerance depending if they were cultured in mono or in coculture 
biofilms. Furthermore, different MBEC were also calculated according to the treatment concentration that erad-
icated ≥99% of the biofilms76. After 15 h of incubation with antibiotics, biofilms were washed with 1X PBS and 
scraped off each well and subsequently sonicated and vortexed as previously detailed. Serial dilutions were then 
plated on selective agar plates.
Statistics. Differences in bacterial CFUs/mL and CFUs/well between time points or strains were analyzed 
using one-way ANOVA with Dunnett’s multiple comparison test using GraphPad Prism 6.0 software. To com-
pare the significance between the percentages of bacterial CFUs that remained in the coculture biofilm after 
gentamicin and ciprofloxacin treatment compared to those calculated in the monoculture biofilms, we used the 
χ2 test77.
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